Delivery Order SPE2DB22D1017-SPE2DB25FG1AS
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Rifampin 150 mg capsules (30-count units) with a contract ceiling value of $1,909.54. This firm fixed-price, competitively awarded delivery order is scheduled for completion by June 17, 2025, with performance at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation and represents one...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,825.87 on April 21, 2025, for the supply of Rifampin 300 mg capsules (60-count units). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and requires delivery by April 22, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Rifampin 300 mg capsules (60-count) with a contract ceiling value of $1,200.66. This is a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Rifampin 300 mg capsules (60-count units) valued at $7,204.23 under firm fixed pricing. This non-set-aside, competitively awarded delivery order is scheduled for completion by September 19, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under the vendor's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Rifampin 300 mg capsules in unit dose packages of 100 units. This competitively awarded contract, valued at $2,276.64 with firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The order is scheduled for completion by August 18, 2025, with fulfillment performed at the contractor's facility in...
- The Defense Logistics Agency awarded a $1,069.22 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Rifampin 150 mg capsules (30-count unit). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a single delivery order under the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,439.74 on August 14, 2025, for the supply of Rifampin 300 mg capsules (60-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 15, 2025, and performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Rifampin 150 mg capsules in quantities of 30 units. This non-set-aside, competitively awarded contract is structured as a firm fixed-price delivery order with a ceiling value of $1,137.07 and an ultimate completion date of September 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a $77,696.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $86,447.52 to AmerisourceBergen Drug Corp for the supply of Rifampin Capsules. This contract, issued on July 14, 2025, with an ultimate completion date of July 15, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation. The award represents a competitive procurement action, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG1ASDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $6,675.68. This is a firm fixed-price delivery order executed under a competitive, non-set-aside procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 25, 2025. This delivery order is a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's IDC with DLA enables it to supply a diverse portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers. The Rifampin order under this delivery order fulfills immediate pharmaceutical supply needs within the broader framework of the company's extensive federal medical supply contract, reflecting its established capability to meet competitive federal procurement requirements for military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 4/24/25 |